Skip to main content
Signal8

Hagan Joseph P

SEC insider (Form 3/4/5 filer). CIK 0001465278. Chief Executive Officer at Regulus Therapeutics Inc. (RGLS). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.

Companies Hagan Joseph P has filed insider reports for

  • Regulus Therapeutics Inc. (RGLS): Director, Officer, Chief Executive Officer
Hagan Joseph P profile photo

Hagan Joseph P

CIK: 0001465278

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Regulus Therapeutics Inc. logo
RGLS

Regulus Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jun 25, 2025
    Disposition
    Direct
    571.6K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 30, 2025
    Purchase
    Direct
    50K shares at avg. $1.09$54K
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 30, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.4M shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 14, 2025
    Sale
    Direct
    11.8K shares at avg. $1.26$15K
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 13, 2025
    Sale
    Direct
    115.3K shares at avg. $1.26$146K
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 9, 2025
    Award
    Direct
    218.8K shares at avg. $1.36$298K
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jan 9, 2025
    Award
    Direct
    62K shares at avg. $1.30$81K

1-7 of 7